(Q43047742)

12 November 2017

title

Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy (English)

1 reference

12 November 2017

0 references

D A Freshwater

1

1 reference

12 November 2017

K O'Donnell

series ordinal

2

1 reference

12 November 2017

D J Mutimer

series ordinal

3

1 reference

12 November 2017

publication date

1 February 2008

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

15

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

115-119

1 reference

Chronic hepatitis C treatment patterns in African American patients: an update

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Racial differences in response rates to consensus interferon in HCV infected patients naive to previous therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Chronic hepatitis C in African Americans and other minority groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Racial differences in the relationship between hepatitis C infection and iron stores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Differences in treatment outcome for hepatitis C among ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Hepatitis C in a Los Angeles public hepatitis clinic: demographic and biochemical differences associated with race-ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

Changes in hepatitis C-related liver disease in a large clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2007.00899.X

10.1111/J.1365-2893.2007.00899.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference